Bloomberg Law
Free Newsletter Sign Up
Login
BROWSE
Bloomberg Law
Welcome
Login
Advanced Search Go
Free Newsletter Sign Up

FDA Cancer Chief Mulls NCI Partnership to Increase US Study Size

Nov. 17, 2022, 9:01 PM

The National Cancer Institute could handle US enrollment of studies testing cancer drugs under a proposal floated by FDA’s cancer chief as part of a larger effort to improve clinical trials.

Richard Pazdur, director of the Food and Drug Administration’s Oncology Center of Excellence, proposed the idea Thursday as a potential solution to ensure the data used to approve cancer therapies in the US represent the nation’s population.

Drug companies have increasingly moved their clinical trials offshore, and both Pazdur and FDA Commissioner Robert M. Califf, who was on the same panel, said multiregional clinical trials are a good ...